
The biotech landscape is shifting. After a few years of cautious funding, more venture capit...
The biotech landscape is shifting. After a few years of cautious funding, more venture capit...
Explore DE&I in Life Sciences: Insights from 120 Industry LeadersThis guide covers:Hones...
In an industry where headlines often read '$X billion invested,' it's easy to gloss over the...
As Q3 wraps up and we move closer to the end of the year, it’s worth noting what the investm...
Let’s not shy away from it—the biotech sector has undeniably seen a decline in M&A and f...